Our Portfolio
|
|
|
|||||
Alvine PharmaceuticalsDeveloping therapeutics for autoimmune/gastrointestinal diseases. |
![]() |
JiWireWiFi Ad Network. |
|
|||
|
|
|
|||||
AmarinPursuing several compelling indications through world class lipid science expertise. |
![]() |
LV SensorsDesigns and builds next generation sensing devices. |
|
|||
|
|
|
|||||
AnesivaSpecialty Pharmaceutical. |
![]() |
NeoconixSemiconductor Interconnect Technology. |
||||
|
|
|
|||||
AxentisSoftware Solutions for Corporate Goverance. |
Novasys MedicalMedical Device for Treatment of Stress Urinary Incontinence. |
|||||
|
|
|
|||||
AxiomOutsourced Legal Services. |
![]() |
Pharmos PharmaceuticalsPharmaceutical Products for the Treatment of Psychiatric and Neurological Disorders. |
![]() |
|||
|
|
|
|||||
Belair NetworksMetro WiFi Mesh Systems. |
PhenomixMolecule Therapies for Diabetes and Inflammation. |
![]() |
||||
|
|
|
|||||
BetawaveAttention-based Digital Media Company. |
![]() |
PowervisionMedical Technology for Intra-Ocular Lens. |
|
|||
|
|
|
|||||
Cadent3-D Technology for the Orthodontic and Dental. |
Presidio PharmaceuticalsSpecialty Pharmaceutical focused on treatment of chronic viral infections. |
![]() |
||||
|
|
|
|||||
CardioKinetixMedical Technology to Treat Congestive Heart Failure. |
Tagsys RFIDItem-level RFID Systems and Tags. |
![]() |
||||
|
|
|
|||||
Cedar PointVoice Switching Equipment for the Cable Operators. |
Valere PowerPower Systems for Carrier Communication Systems. |
|||||
|
|
|
|||||
ChilSemiIntelligent Semiconductor Solutions for the Power Conversion Markets. |
![]() |
ValidityFingerprint Sensors for communication and information devices. |
||||
|
|
|
|||||
Federated Media PublishingContent Publishing Services. |
VyattaOpen Source Networking. |
|
||||
|
|
|
|||||
Hyperion TherapeuticsBiopharmaceutical Company focused on Gastroenterology and Hepatology |
![]() |
World Golf TourSocial Game Publishe |
|
|||
|
|
|
|||||
IteroDeveloper of Value- Added Follow-On and Novel Proteins and Antibodies. |
|
|||||
|
|
|
|||||
| |
||||||
|
|
||||||
|
|
||||||











